ライフサイエンスコーパス: NAD

1 thesis of nicotinamide adenine dinucleotide (NAD(+)).

2 tively respond to increases and decreases in NAD(+).

3 cursor of nicotinamide adenine dinucleotide (NAD).

4 ) gene required for the de novo synthesis of NAD.

5 The ultimate diagnoses were NAD = 43 (49%), CD = 17 (19%), IBS = 14 (16%), NSAIDs =

6 Nicotinamide adenine dinucleotide (NAD), a ubiquitous coenzyme, is required for many physio

7 c development by disrupting the synthesis of NAD, a key factor in multiple biological processes, from

8 However, it remains largely unknown how NAD affects plant response to salt stress.

9 Se-NADES analysis in ICP MS was optimized according to the

10 -Neu5Ac and Neu5Ac, as well as to co-factors NAD and NADH.

11 zed primarily by LDH to generate lactate and NAD(+) and by SpxB and PDHc to generate acetyl-CoA.

12 te intracellular NAD(+) levels by processing NAD(+) and its bio-precursor, nicotinamide mononucleotid

13 cetate and beta-hydroxybutyrate or cofactors NAD(+) and NADH.

14 ith MHV induces a severe attack on host cell NAD(+) and NADP(+) Finally, we show that NAMPT activatio

15 Both Fdx1-dependent reductions of NAD(+) and NADP(+) were cooperative.

16 Here, we show that this decrease in NAD(+) and Nmnat protein levels is specifically due to t

17 different conformational states to exchange NAD(+) and substrate, which may enable PARP enzymes to a

18 olysis of nicotinamide adenine dinucleotide (NAD(+)) and is a candidate molecule for regulating neuro

19 nfinement of the enzyme/cofactor couple (HBD/NAD(+)) and with a stable and selective low-potential fo

20 at mammalian mitochondria can take up intact NAD(+), and identify SLC25A51 (also known as MCART1)-an

21 l benefits to the cell of compartmentalizing NAD(+), and methods for measuring subcellular NAD(+) lev

22 d break repair, we attempted to confirm that NAD+ and ADP-ribose can be used as co-factors by human D

23 ion of ubiquinol and the regeneration of the NAD+ and FAD cofactors, and complex III oxidizes ubiquin

24 ed that human DNA ligase IV can also utilize NAD+ and, to a lesser extent ADP-ribose, as the source o

25 NADH and NAD(+) are a ubiquitous cellular redox couple.

26 tabolism, how different subcellular pools of NAD(+) are established and regulated, and how free NAD(+

27 The numerous biological roles of NAD(+) are organized and coordinated via its compartment

28 ated with nominally significant increases in NAD(+), arginine, saturated long chain free fatty acids,

29 ) or a chain of ADPR units to proteins using NAD as the source of ADPR.

30 Metabolism of beta-NAD at the neuroeffector junction (NEJ) is likely to be

31 DP-ribose) (PAR) is rapidly synthesized from NAD(+) at sites of DNA damage to facilitate repair, but

32 RP1) gene, leading to a higher intracellular NAD(+) availability, beneficial for a sufficient provisi

33 ood lactate:pyruvate ratio and improved NADH:NAD(+) balance in the heart and brain.

34 cket that display peptide-bond flipping upon NAD(+) binding in proper NADH dehydrogenases.

35 Disruption of the NAD(+)-binding site or the ARM-TIR interaction caused co

36 response to DNA damage and occupancy of the NAD(+)-binding site, the interaction of HPF1 with PARP1

37 that the NadA domain of QS is important for NAD biosynthesis, and NAD participates in plant response

38 n occur independent of genetic disruption of NAD biosynthesis.

39 ental and nutritional factors that influence NAD(+) biosynthesis and renal resilience may lead to nov

40 highlights the importance of NAMPT-mediated NAD(+) biosynthesis in the production of cisplatin-induc

41 egulation and interconnection among multiple NAD(+) biosynthesis pathways are incompletely understood

42 Nmnat activities are essential for all NAD(+) biosynthesis routes, and understanding the regula

43 etase enzyme NadE catalyzes the last step of NAD(+) biosynthesis, converting nicotinic acid adenine d

44 e riboside (NR), while down-regulating other NAD biosynthetic pathways.

45 sphoribosyltransferase (NAMPT), an essential NAD(+) biosynthetic enzyme in skeletal muscle, decreased

46 ted transport system for NADP(+) and luminal NAD(+) biosynthetic enzymes integrate signals from a che

47 mitochondrial complex III but can regenerate NAD+ by expression of the NADH oxidase from Lactobacillu

48 NAD(+) can directly and indirectly influence many key ce

49 onical 5' nicotinamide adenine dinucleotide (NAD(+)) cap can tag certain transcripts for degradation

50 esence of nicotinamide adenine dinucleotide (NAD)-capped RNAs in mammalian cells and a role for DXO a

51 and the Nudix hydrolase Nudt12 in decapping NAD-capped RNAs (deNADding) in cells.

52 Here, we reveal a link between NAD(+) capping and tissue- and hormone response-specific

53 transcripts displaying a high proportion of NAD(+) capping are instead processed into RNA-dependent

54 Despite this importance, whether NAD(+) capping dynamically responds to specific stimuli

55 iously uncharacterized and essential role of NAD(+) capping in dynamically regulating transcript stab

56 ate most of the incomplete and non-canonical NAD caps through their decapping, deNADding and pyrophos

57 merization of TIR effector domains and rapid NAD(+) cleavage.

58 tal structure of RgNanOx in complex with the NAD(+) cofactor showed a protein dimer with a Rossman fo

59 ersensitivity to salt stress, but not affect NAD concentration.

60 FiNad sensors cover physiologically relevant NAD(+) concentrations and sensitively respond to increas

61 gulates signaling by controlling subcellular NAD(+) concentrations.

62 R) is an NAD+ precursor that boosts cellular NAD+ concentrations.

63 A major family of NAD(+) consumers in mammalian cells are poly-ADP-ribose-

64 n poly (ADP-ribose) polymerase-1 (PARP-1); a NAD(+)-consuming enzyme activated by strand break interm

65 gy metabolism and are substrates for several NAD-consuming enzymes (e.g. poly(ADP-ribose) polymerases

66 her expression of CD73 impacts intracellular NAD(+) content and NAD(+)-dependent DNA repair capacity.

67 1 decreases mitochondrial-but not whole-cell-NAD(+) content, impairs mitochondrial respiration, and b

68 o salt stress, indicating that the decreased NAD contents in the mutant were responsible for its hype

69 me of the nicotinamide adenine dinucleotide (NAD) de novo synthesis pathway.

70 transcripts for degradation mediated by the NAD(+) decapping enzyme DXO1.

71 Our data show that NAD deficiency as a cause of embryo loss and congenital

72 ates that congenital malformations caused by NAD deficiency can occur independent of genetic disrupti

73 expand the genotypic spectrum of congenital NAD deficiency disorders and further implicate mutation

74 variant in Haao, which alone does not cause NAD deficiency or malformations, the incidence of embryo

75 has bi-allelic missense variants that cause NAD deficiency-dependent malformations.

76 s dietary precursor tryptophan, resulting in NAD deficiency.

77 artments, and many are known targets of the (NAD(+))-dependent desuccinylase SIRT5.

78 We found that NAD(+)-dependent ADP-ribosylation of histone H2B-Glu35 b

79 Sirtuin 1 (Sirt1) is a NAD(+)-dependent deacetylase capable of countering age-r

80 Sirtuin 6 (SIRT6) is a nuclear NAD(+)-dependent deacetylase of histone H3 that regulate

81 SIRT1 (Sir2) is an NAD(+)-dependent deacetylase that plays critical roles i

82 Sirtuin 1 (SIRT1), an NAD(+)-dependent deacetylase, is a key regulator of cell

83 SIRT1, a NAD(+)-dependent deacetylase, is pivotal in regulating h

84 ensor of the cell, belonging to the class of NAD(+)-dependent deacetylases.

85 mechanisms that distinguish SIRT6 from other NAD(+)-dependent deacylases.

86 rase activity catalyzes the final two steps, NAD(+)-dependent dehydrogenation and iron chelation.

87 ted a fluorescence-based assay for measuring NAD(+)-dependent desuccinylation activity in cell lysate

88 was critical to approach the initial rate of NAD(+)-dependent desuccinylation activity in crude cell

89 Sirtuins have been shown to possess NAD(+)-dependent desuccinylation activity in vitro and i

90 D73 impacts intracellular NAD(+) content and NAD(+)-dependent DNA repair capacity.

91 is also an essential cofactor for non-redox NAD(+)-dependent enzymes, including sirtuins, CD38 and p

92 containing dehydrogenase FdsABG is a soluble NAD(+)-dependent formate dehydrogenase and a member of t

93 NAD(+)-dependent maintenance of renal tubular metabolic

94 The NAD+-dependent deacetylase and mono-ADP-ribosyl transfer

95 Mechanistically, SIRT2, an NAD+-dependent deacetylase, protected neurons from cispl

96 NAD-dependent deacetylase sirtuin-1 (SIRT1) is a class I

97 d by prolonged fasting intervals, increasing NAD-dependent deacetylase sirtuin-1 signaling important

98 We further demonstrated that the NAD-dependent protein deacetylase, SIRT7, and the FOXO4

99 NAD(+) depletion and autophagy induced by NAMPT inhibito

100 However, the potential impact of NAD(+) depletion on the brain tumor microenvironment has

101 ipts related to the hydrolase activity (e.g. NAD+ diphosphatase), which were significantly upregulate

102 Here, we provide evidence that NAD+ does not enhance ligation by pre-adenylated DNA lig

103 luorescent indicators, FiNad, for monitoring NAD(+) dynamics in living cells and animals.

104 findings reveal a direct, underlying role of NAD dysregulation when telomeres are short and underscor

105 the treatment of conditions associated with NAD(+) dysregulation.

106 Measuring metabolism of 1,N(6) -etheno-NAD (eNAD) in colonic tunica muscularis and in SMCs, ICC

107 etermining the degradation of 1,N(6) -etheno-NAD (eNAD) in colonic tunica muscularis of wild-type, Cd

108 senolytics, metformin, acarbose, spermidine, NAD(+) enhancers and lithium.

109 Se-NADES extraction was optimized by an experimental design

110 The NADES-extraction is a green procedure with 2 penalty poi

111 cer types and is essential for supplementing NAD+ for glycolysis and NADH for oxidative phosphorylati

112 tate dehydrogenase-catalyzed regeneration of NAD(+) from GAPDH-generated NADH because an increased NA

113 asing oxidative phosphorylation (OXPHOS) and NAD(+) generation.

114 We find that NOCT increases NAD(H) and decreases NADP(H) levels in a manner dependen

115 wed that positive electric field between the NAD(H) binding sites on LDH and GAPDH tetramers can merg

116 trate, removing the 2' phosphate to generate NAD(H), and is a direct regulator of oxidative stress re

117 the LDH-GAPDH complex can be an extension of NAD(H)-channeling within each tetramer.

118 NAD(H)-channeling within the LDH-GAPDH complex can be an

119 amide riboside, and CD38 inhibition improved NAD homeostasis, thereby alleviating telomere damage, de

120 d the axon death molecule dSarm, but not its NAD(+) hydrolase activity, was required cell autonomousl

121 des in the S-nitrosylation assay, 5.8 in the NAD(+) hydrolysis assay, and 6.8 in the enzymatic ADP-ri

122 AKI), substantial decreases in the levels of NAD(+) impair energy generation and, ultimately, the cor

123 analyzing the subcellular redox dynamics of NAD in living plant tissues has been challenging.

124 Although the central role of NAD in plant metabolism and its regulatory role have bee

125 Most NAD(+) in mammalian cells is synthesized via the NAD(+)

126 Here, we established live monitoring of NADH/NAD(+) in plants using the genetically encoded fluoresce

127 abilized by binding of SARM1's own substrate NAD+ in an allosteric location, away from the catalytic

128 y that depletes the key cellular metabolite, NAD+, in response to nerve injury.

129 However, much remains to be learnt about how NAD(+) influences human health and ageing biology.

130 ture of persistent PARP1 foci and identified NAD+ interacting residues involved in the PARP1 exchange

131 Moreover, mutation analyses of the NAD+ interacting residues of PARP1 showed that PARP1 can

132 acillus cereus The geometry of the substrate-NAD(+) interactions is finely arranged to promote hydrid

133 ndrial respiration, and blocks the uptake of NAD(+) into isolated mitochondria.

134 a mammalian transporter capable of importing NAD(+) into mitochondria.

135 NAD is the substrate for the CD157- and CD38-dependent p

136 NAD(+) is a central metabolite participating in core met

137 +) levels also affect DNA repair capacity as NAD(+) is a substrate for PARP-enzymes (mono/poly-ADP-ri

138 NAD(+) is also an essential cofactor for non-redox NAD(+

139 NAD(+) is an essential metabolite participating in cellu

140 We show that NAD(+) is an unexpected ligand of the armadillo/heat rep

141 ge in aerobic glycolysis when the demand for NAD(+) is in excess of the demand for ATP.

142 The PARP substrate NAD(+) is synthesized from 5-phosphoribose-1-pyrophospha

143 Nicotinamide adenine dinucleotide (NAD(+)) is a coenzyme for redox reactions, making it cen

144 beta-nicotinamide adenine dinucleotide (beta-NAD) is an important inhibitory motor neurotransmitter i

145 NAD(+), its phosphorylated variant NAD(P)(+), and its re

146 f intracellular NADP(+) with the activity of NAD kinase (NADK).

147 r-expressing BNA2, the first Biosynthesis of NAD(+) (kynurenine) pathway gene, reduces LD accumulatio

148 fm2 oxidizes NADH to maintain high cytosolic NAD levels in supporting robust glycolysis and to transf

149 Increasing NAD levels may have the potential to improve mitochondri

150 Maternal and embryonic NAD levels were deficient.

151 ired enzymatic activity and severely reduced NAD levels.

152 NAD(+) levels also affect DNA repair capacity as NAD(+)

153 NatB exhibit an approximate 50% reduction in NAD(+) levels and aberrant metabolism of NAD(+) precurso

154 precursor nicotinamide riboside (NR) boosts NAD(+) levels and improves diseases associated with mito

155 ralogue of SLC25A51) increases mitochondrial NAD(+) levels and restores NAD(+) uptake into yeast mito

156 ncer, is suggested to regulate intracellular NAD(+) levels by processing NAD(+) and its bio-precursor

157 are established and regulated, and how free NAD(+) levels can control signaling by PARPs and redox m

158 lementation bolsters skeletal muscle ATP and NAD(+) levels causing upregulated angiogenic pathways vi

159 ing the compartmentalization of steady-state NAD(+) levels in cells, as well as how the modulation of

160 UA significantly increased ATP and NAD(+) levels in mice skeletal muscle.

161 by a gradual decline in tissue and cellular NAD(+) levels in multiple model organisms, including rod

162 Reduced intracellular NAD(+) levels suppressed recruitment of the DNA repair p

163 ATP levels and NAD(+) levels were measured using in vivo (31)P NMR and

164 D accumulation during aging is not linked to NAD(+) levels, but is anti-correlated with metabolites o

165 AD(+), and methods for measuring subcellular NAD(+) levels.

166 mapped their biochemical roles in enhancing NAD(+) levels.

167 n E3 ligases in NatB mutants did not restore NAD(+) levels.

168 l derivatives have the potential to modulate NAD(+) levels.

169 e slowed down and even reversed by restoring NAD(+) levels.

170 Therefore, the inhibition of ACMSD increases NAD(+) levels.

171 hanges in nicotinamide adenine dinucleotide (NAD(+)) levels that compromise mitochondrial function tr

172 lay lower nicotinamide adenine dinucleotide (NAD) levels, and an imbalance in the NAD metabolome that

173 s of 5'caps has revealed that in addition to NAD, mammalian RNAs also contain other metabolite caps i

174 Conversely, augmentation of NAD(+) may protect the kidney tubule against diverse acu

175 st that CD38 deletion and supplementation of NAD(+) may protect transected axon cell-autonomously aft

176 These findings suggest that NAD(+) mediates self-inhibition of this central pro-neur

177 ble specialized functions of the NEJ in beta-NAD metabolism by determining the degradation of 1,N(6)

178 in OADH mutants, to the nicotinate-dependent NAD metabolism.

179 t highly sensitive and specific detection of NAD(+) metabolism in live cells and in vivo remains diff

180 Understanding of NAD(+) metabolism provides many critical insights into h

181 In this review, I discuss NAD(+) metabolism, how different subcellular pools of NA

182 ing of the molecular basis and regulation of NAD(+) metabolism.

183 NR supplementation does not affect NAD metabolite concentrations in skeletal muscle.

184 bese men and women increased skeletal muscle NAD+ metabolites, affected skeletal muscle acetylcarniti

185 eotide (NAD) levels, and an imbalance in the NAD metabolome that includes elevated CD38 NADase and re

186 their continued turnover likely to free the NAD(+) molecules.

187 H and Fdx4- and Fdx11-dependent reduction of NAD(+) MS-based mapping identified an Fdx1-binding site

188 nd to trigger this cascade by decreasing the NAD(+) /NADH ratio and NHEJ-repair in vitro and in diabe

189 thesis or increasing ATP hydrolysis restores NAD(+)/NADH homeostasis and proliferation even when gluc

190 This change in NAD(+)/NADH is caused by increased mitochondrial membran

191 nthesis of UDP-glucuronic acid can alter the NAD(+)/NADH ratio via the enzyme UDP-glucose dehydrogena

192 ha-ketoglutarate (alphaKG) abundance and the NAD(+)/NADH ratio, indicating that constitutive endoplas

193 alate-aspartate shuttle, which regulates the NAD+/NADH ratio between the cytosol and mitochondria.

194 he association of citrin with glycolysis and NAD+/NADH ratio led us to hypothesize that it may play a

195 r redox couples in the mitochondrial matrix (NAD, NADP, thioredoxin, glutathione, and ascorbate) are

196 NAD/NADP was replaced by NADP/NADPH.

197 m1(-/-) and DR6(-/-), but not Wld(s) (excess NAD(+)) neurons, are capable of forming spheroids that e

198 is intrinsic to understanding the impact of NAD(+) on cellular signaling and metabolism.

199 These results reveal effects of NAD(+) on metabolism and the circadian system with aging

200 Overall, reversal of these outcomes through NAD(+) or NMN supplementation was independent of CD73.

201 ated DNA ligase IV is dependent upon ATP not NAD+ or ADP-ribose.

202 NAD(+), its phosphorylated variant NAD(P)(+), and its reduced forms NAD(P)/NAD(P)H are all

203 alyzed the flavodoxin-dependent reduction of NAD(P)(+), Fdx2-dependent oxidation of NADH and Fdx4- an

204 sified catalytic mechanisms and evolution of NAD(P)(+)-dependent ALDHs.

205 abolic pathway, L-AHG is first oxidized by a NAD(P)(+)-dependent dehydrogenase (AHGD), which is a key

206 ted variant NAD(P)(+), and its reduced forms NAD(P)/NAD(P)H are all redox cofactors with key roles in

207 trate two-photon autofluorescence imaging of NAD(P)H and FAD to nondestructively resolve spatiotempor

208 iant NAD(P)(+), and its reduced forms NAD(P)/NAD(P)H are all redox cofactors with key roles in energy

209 The analysis also suggests that ATP and NAD(P)H balancing cannot be assessed in isolation from e

210 They display a bright NAD(P)H fluorescence signal and low uptake of voltage-de

211 fluxes were greatly in excess of demand for NAD(P)H for biosynthesis and larger than those measured

212 al redox ratio measurements revealed reduced NAD(P)H levels in LECs potentially due to increased NAD(

213 One of these, the putative NAD(P)H nitroreductase YfkO, has been reported to be inv

214 eveloped to track and categorise how ATP and NAD(P)H pools are affected in the presence of a new path

215 , we report that the cytosolic flavoprotein, NAD(P)H quinone dehydrogenase 1 (Nqo1), is strongly over

216 own-regulation of NRF2 and its targets NQO1 (NAD(P)H quinone dehydrogenase 1) and SLC7A11 (solute car

217 levels in LECs potentially due to increased NAD(P)H utilization to maintain redox homeostasis.

218 substrate interactions and coupling of H(2), NAD(P)H, and Fdx remain to be resolved.

219 catalyzed electron transfer reactions among NAD(P)H, flavodoxin, and several ferredoxins, thus funct

220 was found to be a single component monomeric NAD(P)H-dependent FAD-containing monooxygenase having a

221 te (P5C) to proline through the oxidation of NAD(P)H.

222 erived macrophages had greater redox ratios [NAD(P)H/FAD intensity] compared with passively migrating

223 NAD(P)H:quinone oxidoreductase 1 (NQO1) and mitochondria

224 Elevated expression of NAD(P)H:quinone oxidoreductase 1 (NQO1) is frequent in p

225 compound, in contrast to its next of a kind, NAD(P)H:quinone oxidoreductase 1 (NQO1).

226 glycerides alongside increased activities of NAD(P)H:Quinone Oxidoreductase 1, Carnitine Palmitoyl-Co

227 of QS is important for NAD biosynthesis, and NAD participates in plant response to salt stress by aff

228 e EcD-based biosensor that incorporates ADH, NAD(+), Pd-NPs and Nafion showed no loss of enzyme activ

229 Nicotinamide adenine dinucleotide (NAD(+)) plays a critical role in energy metabolism and b

230 lformations and the importance of sufficient NAD precursor consumption during pregnancy.

231 Supplementation with the NAD precursor, nicotinamide riboside, and CD38 inhibitio

232 9 days of oral nicotinamide riboside (NR), a NAD precursor.RESULTSWe demonstrated that HF is associat

233 ere, we reveal that supplementation with the NAD(+) precursor nicotinamide riboside (NR) markedly rep

234 that the nicotinamide adenine dinucleotide (NAD(+) ) precursor nicotinamide riboside (NR) boosts NAD

235 Nicotinamide riboside (NR) is an NAD+ precursor that boosts cellular NAD+ concentrations.

236 milar malformations when their supply of the NAD precursors tryptophan and vitamin B3 in the diet was

237 ed a head-to-head comparison study of common NAD(+) precursors in various organisms and mapped their

238 in NAD(+) levels and aberrant metabolism of NAD(+) precursors, changes that are associated with a de

239 pyruvate carrier (UK5099) decreased the NADH/NAD(+) ratio and reduced NF-kappaB activation.

240 ith lactate increased the intracellular NADH/NAD(+) ratio and upregulated NF-kappaB activation after

241 Our work identifies an elevated hepatic NADH/NAD(+) ratio as a latent metabolic parameter that is sha

242 As the intracellular NADH:NAD(+) ratio can be in near equilibrium with the circula

243 d the resultant increase in cytoplasmic NADH/NAD(+) ratio diverts glucose precursors away from glucon

244 directly lowering the hepatic cytosolic NADH/NAD(+) ratio in mice.

245 PDH-generated NADH because an increased NADH:NAD(+) ratio inhibits GAPDH.

246 The cellular NADH/NAD(+) ratio is fundamental to biochemistry, but the ext

247 changes in the extramitochondrial-free NADH:NAD(+) ratio signaled through the CtBP family of NADH-se

248 marker of an elevated hepatic cytosolic NADH/NAD(+) ratio, also known as reductive stress.

249 An elevated intracellular NADH:NAD(+) ratio, or 'reductive stress', has been associated

250 ate ratio, normalized the intracellular NADH:NAD(+) ratio, upregulated glycolytic ATP production and

251 the nicotinamide adenine dinucleotide (NADH/NAD(+)) ratio, and decreased intracellular glutathione l

252 ry, we established a technique for in planta NAD redox monitoring to deliver important insight into t

253 Further, decreased NAD(+) reduced the capacity to repair DNA damage induced

254 s exceeds the rate of ATP turnover in cells, NAD(+) regeneration by mitochondrial respiration becomes

255 This two-step reaction is associated to NAD(+) regeneration, essential for glycolysis.

256 dro-N-acetylneuraminic acid intermediate and NAD(+) regeneration.

257 impairs mitochondrial electron transport and NAD(+) regeneration.

258 s, and late evening activity are restored by NAD(+) repletion to youthful levels with NR.

259 NAD(+) repletion via nicotinamide riboside ameliorated d

260 utant in a dead-end complex with octanal and NAD(+) reveals an apolar binding site primed for aliphat

261 are sensitive to selective inhibition of the NAD(+) salvage pathway enzyme nicotinamide phosphoribosy

262 ent with FK866, a selective inhibitor of the NAD(+) salvage pathway enzyme nicotinamide phosphoribosy

263 +) in mammalian cells is synthesized via the NAD(+) salvage pathway, where nicotinamide phosphoribosy

264 s and thereby sustain the stress-induced NMN/NAD(+) salvage pathway.

265 Katsuyama et al., demonstrated that the CD38/NAD/Sirtuin1/EZH2 axis reduces cytolytic CD8(+) T cell f

266 icotinic acid adenine dinucleotide (NaAD) to NAD(+) Some members of the NadE family use l-glutamine a

267 we analyzed the effect of CD38 deletion and NAD(+) supplementation on neuronal death and glial activ

268 of PARP-1 on H2B requires NMNAT-1, a nuclear NAD(+) synthase, which directs PARP-1 catalytic activity

269 tion of additional genes involved in de novo NAD synthesis as potential causes of complex birth defec

270 1 represents an additional gene required for NAD synthesis during embryogenesis, and NADSYN1 has bi-a

271 ession of genes encoding enzymes for salvage NAD synthesis from nicotinamide (NAM) and nicotinamide r

272 to the rare cases of biallelic mutations in NAD synthesis pathway genes.

273 s in cells, as well as how the modulation of NAD(+) synthesis dynamically regulates signaling by cont

274 d cycle, OX-PHOS, nicotinamide dinucleotide (NAD(+) ) synthesis, and reversed the defects in Abeta ph

275 es of the nicotinamide adenine dinucleotide (NAD) synthesis pathway, are causative of congenital malf

276 Markers of increased NAD+ synthesis-nicotinic acid adenine dinucleotide and m

277 sal bi-allelic variants in NADSYN1, encoding NAD synthetase 1, the final enzyme of the nicotinamide a

278 The prokaryotic NAD synthetase enzyme NadE catalyzes the last step of NA

279 Here we show that the Homo sapiens NAD(+) synthetase (hsNadE) lacks substrate specificity f

280 This bifunctional enzyme couples the NAD(+) synthetase and glutaminase activities through an

281 report the crystal structures of hsNadE and NAD(+) synthetase from M. tuberculosis (tbNadE) with syn

282 ich catalyze the transfer of ADP-ribose from NAD(+) to macromolecular targets (namely, proteins, but

283 These data suggest that when demand for NAD(+) to support oxidation reactions exceeds the rate o

284 This binding of NAD(+) to the ARM domain facilitated the inhibition of t

285 t respond to the alarmone ppGpp, to PRPP, to NAD(+), to adenosine and cytidine diphosphates, and to p

286 d by DCF/dihydroethidium staining, perturbed NAD-to-NADH and glutathione-to-glutathione disulfide rat

287 nknown function-as a mammalian mitochondrial NAD(+) transporter.

288 Mitochondrial NAD(+) transporters have been identified in yeast and pl

289 e into yeast mitochondria lacking endogenous NAD(+) transporters.

290 s the source of the adenylate group and that NAD+, unlike ATP, enhances ligation by supporting multip

291 together, these findings place Rho-actin and NAD(+) upstream of spheroid formation and may suggest th

292 ses mitochondrial NAD(+) levels and restores NAD(+) uptake into yeast mitochondria lacking endogenous

293 NAD was replaced by NADP.

294 genes required for the de novo synthesis of NAD were previously identified in individuals with multi

295 Different NADES were evaluated, and lactic acid:glucose (LGH) show

296 eased 15-hydroxyprostaglandin dehydrogenase [NAD((+))], which degrades eicosanoids, was observed in E

297 ) inhibited alphaKGDH activity and increased NAD(+), which induced SIRT1-dependent autophagy in both

298 -CoA generated by PFL was used to regenerate NAD(+) with a subset used in capsule production, while t

299 Supplementation of NAD(+) with nicotinamide riboside slowed the axon degene

300 with metabolic disease and reduced levels of NAD(+), yet whether changes in nucleotide metabolism con